| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 6.79e-09 | 11 | 139 | 5 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.63e-06 | 32 | 139 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.05e-05 | 42 | 139 | 5 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.00e-04 | 130 | 139 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.45e-04 | 20 | 139 | 3 | GO:0061665 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.84e-06 | 31 | 138 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 3.44e-06 | 35 | 138 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 8.55e-06 | 20 | 138 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.39e-05 | 9 | 138 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.40e-05 | 10 | 138 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | polyadenylation-dependent RNA catabolic process | 4.44e-05 | 2 | 138 | 2 | GO:0043633 | |
| GeneOntologyBiologicalProcess | polyadenylation-dependent ncRNA catabolic process | 4.44e-05 | 2 | 138 | 2 | GO:0043634 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 7.98e-05 | 13 | 138 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.01e-04 | 14 | 138 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.33e-04 | 3 | 138 | 2 | GO:0060212 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 6.10e-08 | 32 | 139 | 6 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 6.10e-08 | 32 | 139 | 6 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 5.10e-07 | 45 | 139 | 6 | GO:1902562 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.78e-06 | 14 | 139 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 5.33e-06 | 18 | 139 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 8.35e-06 | 20 | 139 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.57e-05 | 8 | 139 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.34e-05 | 10 | 139 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.91e-05 | 94 | 139 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 6.90e-05 | 104 | 139 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 8.96e-05 | 109 | 139 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | cation channel complex | 1.80e-04 | 235 | 139 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 2.58e-04 | 19 | 139 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | inclusion body | 3.38e-04 | 90 | 139 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.51e-04 | 21 | 139 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | TRAMP complex | 4.33e-04 | 5 | 139 | 2 | GO:0031499 | |
| GeneOntologyCellularComponent | nuclear pore | 5.74e-04 | 101 | 139 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 6.69e-04 | 26 | 139 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | dense body | 9.02e-04 | 7 | 139 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.79e-04 | 378 | 139 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | NHLRC1 RGPD4 RGPD8 ACTN4 RYR3 NCOR1 CDK5R1 ZNF35 KCND3 MLC1 RGPD3 SERINC5 GOLGA8A MYO16 WWC1 | 1.41e-03 | 934 | 139 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | host cell | 1.53e-03 | 9 | 139 | 2 | GO:0043657 | |
| GeneOntologyCellularComponent | actin filament | 2.95e-03 | 146 | 139 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.20e-03 | 91 | 139 | 4 | GO:0008076 | |
| Domain | Actin_CS | 8.38e-08 | 16 | 138 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 1.18e-07 | 17 | 138 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.62e-07 | 18 | 138 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.19e-07 | 19 | 138 | 5 | PS01132 | |
| Domain | Grip | 9.04e-07 | 11 | 138 | 4 | SM00755 | |
| Domain | GRIP | 9.04e-07 | 11 | 138 | 4 | PF01465 | |
| Domain | Ran_BP1 | 1.35e-06 | 12 | 138 | 4 | PF00638 | |
| Domain | RANBD1 | 1.35e-06 | 12 | 138 | 4 | PS50196 | |
| Domain | GRIP_dom | 1.35e-06 | 12 | 138 | 4 | IPR000237 | |
| Domain | GRIP | 1.35e-06 | 12 | 138 | 4 | PS50913 | |
| Domain | RanBD | 1.94e-06 | 13 | 138 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 1.94e-06 | 13 | 138 | 4 | IPR000156 | |
| Domain | Actin | 2.98e-06 | 31 | 138 | 5 | IPR004000 | |
| Domain | Actin | 2.98e-06 | 31 | 138 | 5 | PF00022 | |
| Domain | ACTIN | 2.98e-06 | 31 | 138 | 5 | SM00268 | |
| Domain | Rab_bind | 1.35e-05 | 7 | 138 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.35e-05 | 7 | 138 | 3 | IPR032023 | |
| Domain | - | 4.56e-05 | 10 | 138 | 3 | 1.10.220.60 | |
| Domain | - | 3.22e-04 | 4 | 138 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 3.22e-04 | 4 | 138 | 2 | PS51139 | |
| Domain | GTF2I | 3.22e-04 | 4 | 138 | 2 | PF02946 | |
| Domain | GTF2I | 3.22e-04 | 4 | 138 | 2 | IPR004212 | |
| Domain | TRP_2 | 7.97e-04 | 6 | 138 | 2 | PF08344 | |
| Domain | TRP_dom | 7.97e-04 | 6 | 138 | 2 | IPR013555 | |
| Domain | TRPC_channel | 1.11e-03 | 7 | 138 | 2 | IPR002153 | |
| Domain | PAP_assoc | 1.11e-03 | 7 | 138 | 2 | PF03828 | |
| Domain | PAP_assoc | 1.11e-03 | 7 | 138 | 2 | IPR002058 | |
| Domain | CH | 1.36e-03 | 65 | 138 | 4 | SM00033 | |
| Domain | ACTINS_1 | 1.47e-03 | 8 | 138 | 2 | PS00406 | |
| Domain | Ion_trans_dom | 1.58e-03 | 114 | 138 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.58e-03 | 114 | 138 | 5 | PF00520 | |
| Domain | CH | 1.79e-03 | 70 | 138 | 4 | PF00307 | |
| Domain | - | 1.89e-03 | 71 | 138 | 4 | 1.10.418.10 | |
| Domain | CH | 2.09e-03 | 73 | 138 | 4 | PS50021 | |
| Domain | CH-domain | 2.31e-03 | 75 | 138 | 4 | IPR001715 | |
| Domain | - | 2.48e-03 | 248 | 138 | 7 | 1.25.40.20 | |
| Domain | ANK | 2.66e-03 | 251 | 138 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 2.78e-03 | 253 | 138 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.84e-03 | 254 | 138 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.84e-03 | 254 | 138 | 7 | PS50297 | |
| Domain | TRP_channel | 2.85e-03 | 11 | 138 | 2 | IPR004729 | |
| Domain | NTP_transf_2 | 2.85e-03 | 11 | 138 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 2.85e-03 | 11 | 138 | 2 | IPR002934 | |
| Domain | Ankyrin_rpt | 3.37e-03 | 262 | 138 | 7 | IPR002110 | |
| Domain | PH_dom-like | 4.43e-03 | 426 | 138 | 9 | IPR011993 | |
| Domain | Ank_2 | 5.30e-03 | 215 | 138 | 6 | PF12796 | |
| Domain | IRK | 6.08e-03 | 16 | 138 | 2 | PF01007 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 6.08e-03 | 16 | 138 | 2 | IPR013518 | |
| Domain | - | 6.08e-03 | 16 | 138 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 6.08e-03 | 16 | 138 | 2 | IPR016449 | |
| Domain | Ank | 7.01e-03 | 228 | 138 | 6 | PF00023 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.70e-05 | 58 | 92 | 5 | MM14736 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 6.43e-05 | 65 | 92 | 5 | M38994 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.30e-04 | 40 | 92 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.43e-04 | 41 | 92 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.57e-04 | 42 | 92 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.73e-04 | 43 | 92 | 4 | MM14609 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.95e-04 | 82 | 92 | 5 | M27626 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.04e-04 | 18 | 92 | 3 | MM1549 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 2.04e-04 | 18 | 92 | 3 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 2.04e-04 | 18 | 92 | 3 | M840 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.44e-04 | 47 | 92 | 4 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.88e-04 | 49 | 92 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.11e-04 | 50 | 92 | 4 | MM14610 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.17e-04 | 141 | 92 | 6 | MM15266 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.36e-04 | 51 | 92 | 4 | MM15151 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 4.16e-04 | 5 | 92 | 2 | M49034 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.49e-04 | 55 | 92 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.51e-04 | 58 | 92 | 4 | MM15149 | |
| Pubmed | RGPD4 FLNC KRT7 RGPD8 PCDHGA4 POTEF PSMA2 ACTB ACTG1 ACTN4 ACSL4 POTEE NCOR1 GTF2IRD2B C2CD3 BBX TIMM21 SETD5 RGPD3 UNC5C YLPM1 GTF2IRD2 NAV2 CCAR2 POTEI BAHCC1 RGPD5 | 2.27e-11 | 1442 | 140 | 27 | 35575683 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.86e-09 | 15 | 140 | 5 | 16824795 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 8.72e-09 | 7 | 140 | 4 | 15710750 | |
| Pubmed | 8.12e-08 | 11 | 140 | 4 | 17069463 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNC MAN2B1 EP400 CUL9 TBC1D25 SBNO2 ZNF503 HIVEP3 JAK2 NCOR1 FZR1 CDK5R1 C2CD3 SETD5 BTBD7 NAV2 PCNX1 GAREM1 BAHCC1 | 1.08e-07 | 1105 | 140 | 19 | 35748872 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.49e-07 | 146 | 140 | 8 | 23892456 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.75e-07 | 13 | 140 | 4 | 31427429 | |
| Pubmed | TENT4B RGPD8 POTEF PSMA2 ACTB ACTG1 ACTN4 POTEE ASXL3 KIAA1217 RGPD3 SLC22A5 CCAR2 | 1.76e-07 | 513 | 140 | 13 | 25798074 | |
| Pubmed | 3.32e-07 | 15 | 140 | 4 | 14697343 | ||
| Pubmed | RGPD4 RGPD8 ACTB WDR91 NCOR1 GDA SENP1 UBAP2L KIAA1217 KCNJ10 RGPD3 YLPM1 CCAR2 QSER1 GOLGA8A NUP153 PHLDB2 | 3.69e-07 | 963 | 140 | 17 | 28671696 | |
| Pubmed | KRT7 POTEF PSMA2 NACA ACTB ACTG1 CHD9 ZNF503 POTEE GTF2IRD2B UBAP2L PRMT5 GTF2IRD2 ALDH18A1 PIP5K1B CCAR2 POTEI NUP153 | 9.64e-07 | 1153 | 140 | 18 | 29845934 | |
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 12679033 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.67e-06 | 271 | 140 | 9 | 32433965 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | EP400 NACA ACTB ACTG1 ACTN4 NCOR1 RGPD3 ALDH18A1 CCAR2 NUP153 | 2.02e-06 | 357 | 140 | 10 | 37059091 |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.21e-06 | 7 | 140 | 3 | 11353387 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 30944974 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.21e-06 | 7 | 140 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.21e-06 | 7 | 140 | 3 | 17372272 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 38657106 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 21205196 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 18949001 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 25187515 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 8603673 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 26632511 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 24403063 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 23818861 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 23536549 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 12191015 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 22821000 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 20682751 | ||
| Pubmed | 3.34e-06 | 100 | 140 | 6 | 21800051 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.52e-06 | 8 | 140 | 3 | 21670213 | |
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.52e-06 | 8 | 140 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.52e-06 | 8 | 140 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.52e-06 | 8 | 140 | 3 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.27e-06 | 9 | 140 | 3 | 18394993 | |
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 28100513 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 5.27e-06 | 9 | 140 | 3 | 10556093 | |
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 17887960 | ||
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 11553612 | ||
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 10601307 | ||
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 9733766 | ||
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 28877029 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 7.50e-06 | 10 | 140 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.50e-06 | 10 | 140 | 3 | 8857542 | |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 21859863 | ||
| Pubmed | 9.08e-06 | 334 | 140 | 9 | 30425250 | ||
| Pubmed | 9.40e-06 | 33 | 140 | 4 | 17955473 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.03e-05 | 11 | 140 | 3 | 35771867 | |
| Pubmed | 1.03e-05 | 11 | 140 | 3 | 34110283 | ||
| Pubmed | EP400 KIAA1549 CUL9 CHD9 GIGYF1 MSH6 SENP1 ARHGEF33 TIMM21 MTUS1 SETD5 MTR XYLB WWC1 PHLDB2 BAHCC1 | 1.17e-05 | 1116 | 140 | 16 | 31753913 | |
| Pubmed | 1.20e-05 | 35 | 140 | 4 | 18498732 | ||
| Pubmed | Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. | 1.50e-05 | 37 | 140 | 4 | 18498735 | |
| Pubmed | 1.51e-05 | 130 | 140 | 6 | 12421765 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 1.61e-05 | 2 | 140 | 2 | 21778137 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29116649 | ||
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 1.61e-05 | 2 | 140 | 2 | 22366783 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23689571 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22724068 | ||
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 1.61e-05 | 2 | 140 | 2 | 32588558 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12376540 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15890703 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27625340 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33982216 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 1.61e-05 | 2 | 140 | 2 | 20190513 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18317225 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.61e-05 | 2 | 140 | 2 | 19669888 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 3221869 | ||
| Pubmed | KIBRA promotes prostate cancer cell proliferation and motility. | 1.61e-05 | 2 | 140 | 2 | 27220053 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32116538 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 10066793 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32559291 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21502360 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 6686106 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 213279 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33334799 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33333171 | ||
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 1.61e-05 | 2 | 140 | 2 | 21900491 | |
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 1.61e-05 | 2 | 140 | 2 | 12970363 | |
| Pubmed | Lrp6 is a target of the PTH-activated αNAC transcriptional coregulator. | 1.61e-05 | 2 | 140 | 2 | 29413898 | |
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 1.61e-05 | 2 | 140 | 2 | 19638415 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 1.61e-05 | 2 | 140 | 2 | 3335520 | |
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 1.61e-05 | 2 | 140 | 2 | 9930701 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9288906 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 1577857 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25691062 | ||
| Pubmed | Abnormal expression of urea cycle enzyme genes in juvenile visceral steatosis (jvs) mice. | 1.61e-05 | 2 | 140 | 2 | 1540663 | |
| Pubmed | Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation. | 1.61e-05 | 2 | 140 | 2 | 30026317 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21785467 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26583190 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32326615 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24453217 | ||
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 1.61e-05 | 2 | 140 | 2 | 23756437 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25213992 | ||
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 1.61e-05 | 2 | 140 | 2 | 8482333 | |
| Interaction | UCHL5 interactions | RGPD8 POTEF PSMA2 NACA ACTB ACTG1 BIRC3 ACTN4 CCDC92 POTEE RGPD5 | 1.03e-05 | 319 | 135 | 11 | int:UCHL5 |
| Interaction | RGPD8 interactions | 1.03e-05 | 74 | 135 | 6 | int:RGPD8 | |
| Interaction | RGPD4 interactions | 1.28e-05 | 22 | 135 | 4 | int:RGPD4 | |
| Interaction | ACTG2 interactions | 1.88e-05 | 49 | 135 | 5 | int:ACTG2 | |
| Interaction | MAGEA10 interactions | 2.08e-05 | 50 | 135 | 5 | int:MAGEA10 | |
| Interaction | POTEJ interactions | 2.53e-05 | 52 | 135 | 5 | int:POTEJ | |
| Interaction | RGPD2 interactions | 3.00e-05 | 27 | 135 | 4 | int:RGPD2 | |
| Interaction | UBE2Q2 interactions | 3.00e-05 | 27 | 135 | 4 | int:UBE2Q2 | |
| Interaction | NEK4 interactions | TENT4B RGPD8 POTEF PSMA2 ACTB ACTG1 ACTN4 POTEE ASXL3 KIAA1217 RGPD3 SLC22A5 MTR CCAR2 | 3.71e-05 | 582 | 135 | 14 | int:NEK4 |
| Interaction | ARPC2 interactions | 3.84e-05 | 187 | 135 | 8 | int:ARPC2 | |
| Interaction | TOP3B interactions | FLNC MAN2B1 EP400 KIF1B ACTG1 CUL9 TBC1D25 ACTN4 SBNO2 ZNF503 HIVEP3 JAK2 NCOR1 FZR1 CDK5R1 C2CD3 SETD5 UBAP2L BTBD7 PRMT5 NAV2 PCNX1 GAREM1 BAHCC1 | 3.99e-05 | 1470 | 135 | 24 | int:TOP3B |
| Interaction | SCIN interactions | 4.32e-05 | 58 | 135 | 5 | int:SCIN | |
| Interaction | TENT4A interactions | 6.19e-05 | 12 | 135 | 3 | int:TENT4A | |
| Interaction | ACTC1 interactions | EP400 POTEF ACTB ACTG1 CUL9 ACTN4 TASL POTEE MSH6 FZR1 YLPM1 PAN2 FGD5 POTEI NUP153 | 6.54e-05 | 694 | 135 | 15 | int:ACTC1 |
| Interaction | CALD1 interactions | 7.59e-05 | 265 | 135 | 9 | int:CALD1 | |
| Interaction | B9D2 interactions | 1.31e-04 | 73 | 135 | 5 | int:B9D2 | |
| Interaction | DCTN1 interactions | FLNC KIF1B NACA ACTB ACTG1 BIRC3 TSFM MSH6 FZR1 MTUS1 KIAA1217 WWC1 | 1.32e-04 | 497 | 135 | 12 | int:DCTN1 |
| Interaction | AKIRIN2 interactions | 1.39e-04 | 74 | 135 | 5 | int:AKIRIN2 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 3.08e-05 | 13 | 88 | 3 | 685 | |
| GeneFamily | C2 and WW domain containing | 1.40e-04 | 4 | 88 | 2 | 838 | |
| GeneFamily | Actins | 3.47e-04 | 6 | 88 | 2 | 929 | |
| GeneFamily | Non-canonical poly(A) polymerases | 4.84e-04 | 7 | 88 | 2 | 1318 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.91e-03 | 181 | 88 | 5 | 694 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.40e-03 | 115 | 88 | 4 | 769 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 2.69e-03 | 16 | 88 | 2 | 276 | |
| GeneFamily | CD molecules|Mucins | 4.63e-03 | 21 | 88 | 2 | 648 | |
| GeneFamily | Ankyrin repeat domain containing | 6.56e-03 | 242 | 88 | 5 | 403 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.50e-08 | 200 | 140 | 9 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-07 | 184 | 140 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-07 | 185 | 140 | 8 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-07 | 185 | 140 | 8 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-07 | 185 | 140 | 8 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-07 | 186 | 140 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.38e-07 | 186 | 140 | 8 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.49e-07 | 188 | 140 | 8 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.22e-07 | 198 | 140 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.31e-07 | 199 | 140 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.40e-07 | 200 | 140 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.40e-07 | 200 | 140 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-07 | 200 | 140 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.42e-07 | 156 | 140 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.06e-06 | 168 | 140 | 7 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-06 | 177 | 140 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-06 | 179 | 140 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 181 | 140 | 7 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-06 | 181 | 140 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-06 | 183 | 140 | 7 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-06 | 183 | 140 | 7 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-06 | 184 | 140 | 7 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | P28-Epithelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.94e-06 | 184 | 140 | 7 | 05811d13bd8a602095a3fcf5e55345edadc7b8bf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.94e-06 | 184 | 140 | 7 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-06 | 184 | 140 | 7 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.94e-06 | 184 | 140 | 7 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-06 | 184 | 140 | 7 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.01e-06 | 185 | 140 | 7 | 5bb513e569f3a197d55ae2ca683e202daebabeac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-06 | 185 | 140 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 187 | 140 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 187 | 140 | 7 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.24e-06 | 188 | 140 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-06 | 188 | 140 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 2.32e-06 | 189 | 140 | 7 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-06 | 190 | 140 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.48e-06 | 191 | 140 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.48e-06 | 191 | 140 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-06 | 191 | 140 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.57e-06 | 192 | 140 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.57e-06 | 192 | 140 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-06 | 192 | 140 | 7 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.85e-06 | 195 | 140 | 7 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 198 | 140 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 198 | 140 | 7 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-06 | 199 | 140 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.26e-06 | 199 | 140 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.22e-06 | 134 | 140 | 6 | a4b9163af68e92d047b0005fd2f98aa63846b65b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.38e-06 | 154 | 140 | 6 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 1.44e-05 | 166 | 140 | 6 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 168 | 140 | 6 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 172 | 140 | 6 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 172 | 140 | 6 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-05 | 173 | 140 | 6 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 174 | 140 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 174 | 140 | 6 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.95e-05 | 104 | 140 | 5 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-05 | 176 | 140 | 6 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 177 | 140 | 6 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 177 | 140 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-05 | 178 | 140 | 6 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 178 | 140 | 6 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 179 | 140 | 6 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 179 | 140 | 6 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 179 | 140 | 6 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-05 | 180 | 140 | 6 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 181 | 140 | 6 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 181 | 140 | 6 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.42e-05 | 182 | 140 | 6 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 183 | 140 | 6 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.49e-05 | 183 | 140 | 6 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 183 | 140 | 6 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 183 | 140 | 6 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-05 | 183 | 140 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 140 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 184 | 140 | 6 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-05 | 184 | 140 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 140 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 140 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.65e-05 | 185 | 140 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 185 | 140 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 185 | 140 | 6 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-05 | 186 | 140 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 186 | 140 | 6 | 16092819e9148dfe64f07c737652b6e533e699f7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-05 | 186 | 140 | 6 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-05 | 187 | 140 | 6 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-05 | 187 | 140 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 187 | 140 | 6 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-05 | 187 | 140 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 188 | 140 | 6 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.90e-05 | 188 | 140 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | normal_Lung-MAST_cells|normal_Lung / Location, Cell class and cell subclass | 2.99e-05 | 189 | 140 | 6 | f09e387dc0626536050cd537dda212471a7267c4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 189 | 140 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | normal_Lung-MAST_cells-MAST|normal_Lung / Location, Cell class and cell subclass | 2.99e-05 | 189 | 140 | 6 | fd053209034fca6eaefe0e5ad024ac4548a100c9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.99e-05 | 189 | 140 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 3.08e-05 | 190 | 140 | 6 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 190 | 140 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.17e-05 | 191 | 140 | 6 | 142f98cabf8737b28369315b3d7a0797ded88e03 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.26e-05 | 192 | 140 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-05 | 193 | 140 | 6 | 1fdfe08b0c82248545c29b504ac259b093fde29b | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 3.36e-05 | 193 | 140 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| Disease | Baraitser-Winter syndrome | 1.99e-05 | 2 | 132 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 1.99e-05 | 2 | 132 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 1.99e-05 | 2 | 132 | 2 | C1853623 | |
| Disease | focal segmental glomerulosclerosis (is_implicated_in) | 5.94e-05 | 3 | 132 | 2 | DOID:1312 (is_implicated_in) | |
| Disease | PR interval | CUL9 FIGN HIVEP3 MTUS1 KCND3 SCN10A NAV2 ALDH18A1 PHLDB2 GAREM1 | 8.11e-05 | 495 | 132 | 10 | EFO_0004462 |
| Disease | lymphocyte count | PCDHGA4 POTEF KIF1B ACTB CCDC92 GIGYF1 CPS1 FAM43B SBNO2 NCOR1 GTF2IRD2B CNTN5 SLC22A5 GTF2IRD2 ALDH18A1 USP4 DMRTA1 HNRNPLL | 9.49e-05 | 1464 | 132 | 18 | EFO_0004587 |
| Disease | alcohol dependence measurement | 1.09e-04 | 55 | 132 | 4 | EFO_0007835 | |
| Disease | obsolete_red blood cell distribution width | LVRN EHBP1 EP400 TENT4A CPS1 FZR1 GTF2IRD2B KIAA1217 CNTN5 SLC22A5 YLPM1 GTF2IRD2 CRYBG1 USP4 DMRTA1 MYO16 SLC16A10 | 1.10e-04 | 1347 | 132 | 17 | EFO_0005192 |
| Disease | mean corpuscular hemoglobin concentration | PPP1R21 EP400 POTEF ACTB GIGYF1 URB2 CPS1 OPRD1 FZR1 UBAP2L KIAA1217 CNTN5 DMRTA1 MYO16 SLC16A10 | 1.31e-04 | 1105 | 132 | 15 | EFO_0004528 |
| Disease | radiation-induced disorder | 2.36e-04 | 67 | 132 | 4 | EFO_0009565 | |
| Disease | atrial fibrillation | 2.76e-04 | 371 | 132 | 8 | EFO_0000275 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.45e-04 | 74 | 132 | 4 | DOID:3748 (is_marker_for) | |
| Disease | colorectal cancer | PPP1R21 TRPC6 COLCA1 SBNO2 FZR1 CNTN5 PCNX1 SCPEP1 GOLGA8A MYO16 | 4.01e-04 | 604 | 132 | 10 | MONDO_0005575 |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 4.11e-04 | 7 | 132 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | electrocardiography, PR interval | 4.11e-04 | 7 | 132 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Hyperammonemia | 4.11e-04 | 7 | 132 | 2 | C0220994 | |
| Disease | Uveoretinal Coloboma | 4.11e-04 | 7 | 132 | 2 | C4554007 | |
| Disease | hemorrhoid | 5.34e-04 | 147 | 132 | 5 | EFO_0009552 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 5.46e-04 | 8 | 132 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 5.46e-04 | 8 | 132 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 5.46e-04 | 8 | 132 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 5.46e-04 | 8 | 132 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | mean platelet volume | NHLRC1 PCDHGA4 TRPC3 KIF1B NACA CHD9 ACTN4 CPS1 OPRD1 JAK2 ACSL4 BBX SLC22A5 | 6.76e-04 | 1020 | 132 | 13 | EFO_0004584 |
| Disease | Paroxysmal atrial fibrillation | 6.98e-04 | 156 | 132 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 6.98e-04 | 156 | 132 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.98e-04 | 156 | 132 | 5 | C2585653 | |
| Disease | Congenital ocular coloboma (disorder) | 7.00e-04 | 9 | 132 | 2 | C0009363 | |
| Disease | Atrial Fibrillation | 7.83e-04 | 160 | 132 | 5 | C0004238 | |
| Disease | intestinal atresia (implicated_via_orthology) | 8.73e-04 | 10 | 132 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | Inherited focal segmental glomerulosclerosis | 8.73e-04 | 10 | 132 | 2 | cv:CN327126 | |
| Disease | Congenital neurologic anomalies | 8.73e-04 | 10 | 132 | 2 | C0497552 | |
| Disease | Focal segmental glomerulosclerosis | 8.73e-04 | 10 | 132 | 2 | cv:C0017668 | |
| Disease | Cranioschisis | 8.73e-04 | 10 | 132 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 8.73e-04 | 10 | 132 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | DCHS2 ENPP2 KIF1B ACTN4 NCOR1 WNT16 NAV2 DMRTA1 QSER1 UROS MYO16 WWC1 BAHCC1 | 1.04e-03 | 1069 | 132 | 13 | EFO_0004346 |
| Disease | Other specified cardiac arrhythmias | 1.06e-03 | 11 | 132 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 1.06e-03 | 11 | 132 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 1.06e-03 | 11 | 132 | 2 | C1399226 | |
| Disease | Shortened QT interval | 1.06e-03 | 11 | 132 | 2 | C0151879 | |
| Disease | nucleus accumbens volume change measurement | 1.06e-03 | 11 | 132 | 2 | EFO_0021493 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 1.06e-03 | 11 | 132 | 2 | cv:CN043612 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 1.06e-03 | 11 | 132 | 2 | C2748542 | |
| Disease | homocysteine measurement | 1.15e-03 | 46 | 132 | 3 | EFO_0004578 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.27e-03 | 12 | 132 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | gallbladder carcinoma (is_marker_for) | 1.27e-03 | 12 | 132 | 2 | DOID:4948 (is_marker_for) | |
| Disease | vital capacity | PPP1R21 EHBP1 TENT4B ENPP2 ACTG1 NCOR1 SENP1 PAN2 LRP6 CCAR2 DMRTA1 XYLB MYO16 OTOG | 1.31e-03 | 1236 | 132 | 14 | EFO_0004312 |
| Disease | fibrinogen measurement | 1.48e-03 | 109 | 132 | 4 | EFO_0004623 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 1.50e-03 | 13 | 132 | 2 | cv:C4273714 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.50e-03 | 13 | 132 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Brugada Syndrome 1 | 1.50e-03 | 13 | 132 | 2 | C4551804 | |
| Disease | total brain volume change measurement | 1.74e-03 | 14 | 132 | 2 | EFO_0021504 | |
| Disease | leukemia | 1.94e-03 | 55 | 132 | 3 | C0023418 | |
| Disease | phenylalanine measurement | 1.94e-03 | 55 | 132 | 3 | EFO_0005001 | |
| Disease | P wave duration | 2.01e-03 | 15 | 132 | 2 | EFO_0005094 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.01e-03 | 15 | 132 | 2 | C0428908 | |
| Disease | ureidopropionic acid measurement | 2.29e-03 | 16 | 132 | 2 | EFO_0010542 | |
| Disease | Drug-Induced Liver Disease | 2.33e-03 | 404 | 132 | 7 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 2.33e-03 | 404 | 132 | 7 | C3658290 | |
| Disease | Hepatitis, Toxic | 2.33e-03 | 404 | 132 | 7 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 2.33e-03 | 404 | 132 | 7 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 2.33e-03 | 404 | 132 | 7 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 2.33e-03 | 404 | 132 | 7 | C1262760 | |
| Disease | platelet measurement | 3.00e-03 | 315 | 132 | 6 | EFO_0005036 | |
| Disease | bitter alcoholic beverage consumption measurement | 3.05e-03 | 133 | 132 | 4 | EFO_0010092 | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.40e-03 | 67 | 132 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | gestational age | 3.49e-03 | 138 | 132 | 4 | EFO_0005112 | |
| Disease | citrulline measurement | 3.58e-03 | 20 | 132 | 2 | EFO_0009777 | |
| Disease | ascending aortic diameter | 3.67e-03 | 140 | 132 | 4 | EFO_0021787 | |
| Disease | Animal Mammary Neoplasms | 3.86e-03 | 142 | 132 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 3.86e-03 | 142 | 132 | 4 | C1257925 | |
| Disease | cerebellar cortex volume measurement | 3.94e-03 | 21 | 132 | 2 | EFO_0010291 | |
| Disease | colorectal carcinoma (is_implicated_in) | 4.33e-03 | 22 | 132 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 4.41e-03 | 702 | 132 | 9 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITAFLSSSKPYTEAA | 1026 | Q14146 | |
| DSDPAYSSKVLLLSS | 301 | Q8N163 | |
| GYSSPLTLSDQSSKI | 341 | O60488 | |
| LSGYSLLPLSSETFK | 376 | Q6UWY0 | |
| TTSVKFNAPSLLYGA | 1076 | Q96L91 | |
| YATLAKPSSSLETFF | 201 | Q9Y5Z0 | |
| SGLDKSGYFELPTSS | 486 | Q9P281 | |
| SLSPSYRKATLFEDG | 6 | Q15078 | |
| FPDFSYSASSKIIIS | 406 | Q8WY36 | |
| ASSSSLEKSYELPDG | 231 | P60709 | |
| ASSSSLEKSYELPDG | 231 | P63261 | |
| SESGFLPYSAAVLSK | 446 | Q03828 | |
| SRSESTSEFKPGYSL | 351 | Q9UPC5 | |
| AVPGALDYKSFSTAL | 891 | O43707 | |
| TSPAGSSSAYKLEAA | 681 | A8MVX0 | |
| TYDSSSLPALLFKAR | 381 | Q71F23 | |
| LTFLSPTDLAKAGFY | 181 | Q13489 | |
| LKPGSSYELQLSFSG | 196 | Q6Q4G3 | |
| YFNSSLSLADKGSLP | 66 | Q8N5I2 | |
| ALKSADFSSYLLSEP | 2116 | Q9C0F0 | |
| CLSEYSKSLPGLSTS | 16 | O94779 | |
| SKSLPGLSTSYAALL | 21 | O94779 | |
| ASGESLTLTAPSLSY | 461 | Q2KHR3 | |
| LYDALFSSQSPKDTS | 386 | Q99666 | |
| LYDALFSSQSPKDTS | 386 | O14715 | |
| SLGKSEADYLTFPSG | 46 | O60674 | |
| ASITFFSPSGLTYSL | 191 | P10746 | |
| GSNPYTLKLCFSTSS | 526 | Q8WVV9 | |
| DLPGSSLSSYGEKIF | 331 | Q8NAB2 | |
| YTTPLTDAGKAFSIA | 111 | Q9Y257 | |
| TVLITDAYLPSGSSF | 836 | Q9HCM3 | |
| SYSLLKSSEPGLFAV | 636 | Q9Y5G9 | |
| SFKTGLYLPTSDIDL | 166 | Q8NDF8 | |
| GSKTHTPLLDFSFYS | 351 | Q5TGI0 | |
| TNPSFGTLYSSFLDL | 226 | Q8WXI7 | |
| GTLYSSFLDLSPKGT | 231 | Q8WXI7 | |
| PLFKNTSVSSLYSGC | 13361 | Q8WXI7 | |
| ASSSSLEKSYELPDG | 931 | A5A3E0 | |
| ASSTLLFTLSYPDGS | 676 | Q504Q3 | |
| LFTLSYPDGSKSDKT | 681 | Q504Q3 | |
| LSFSELGYTAATIPK | 66 | Q8NGY5 | |
| LGSRSSESFGKYTSP | 411 | Q5HY92 | |
| YAEKGSSASKFTSIP | 341 | Q9UK17 | |
| GLKNSRSSPSLSDSY | 856 | O75420 | |
| GKLYTTSLATLTSFP | 11 | Q4G0X4 | |
| FTPAISLSASGKYIA | 311 | P78508 | |
| SPNGKLTDFLSFYTL | 391 | O60551 | |
| SFGTYSTKLPFDLSI | 176 | Q5VWC8 | |
| VSGSSSSSKYDPEIL | 146 | Q8IX03 | |
| LSFSSSAGPGLLKAY | 441 | P08729 | |
| EYGSLFLGSASKTTT | 691 | Q9ULD2 | |
| QLYFSSSGKLCSSLP | 456 | Q9Y6X6 | |
| LRSLFGSGYSKSPDS | 1421 | O60333 | |
| KSLSPGLAYTSLLSS | 21 | Q6ZT52 | |
| YCKASLSASSSLEPT | 401 | Q9NQG7 | |
| PSAYSKGFLNSSELS | 156 | P43897 | |
| AGLKLLRSSFSSPTY | 1396 | Q96RV3 | |
| TLYSNSKGLPSSSTF | 496 | O14986 | |
| GKLRASESPSSLIFY | 711 | Q6ZNL6 | |
| SVSGCPKSASYSLES | 691 | Q9H706 | |
| RGSSYSSIPKFSSDA | 2621 | Q14315 | |
| SSSSSTKGTYFPAIL | 1471 | O75581 | |
| FISSSSPSGLYQLDL | 136 | Q8TB73 | |
| ASLSYGPKAASGFIS | 496 | Q6ZMI0 | |
| TLYSFFPKSPALSDA | 6 | P52701 | |
| CYLSLSGNSKAPSSS | 441 | C9JSJ3 | |
| SFSTGLYLPTSDIDL | 266 | Q5XG87 | |
| AGPKFASYLTFSPSE | 646 | P54886 | |
| SLKSSFPGSLTAFCY | 376 | Q9UNX9 | |
| ALATSTLPFQSAKYL | 96 | P41143 | |
| IGLYFLPSSSASSDK | 256 | Q8NGS1 | |
| LYSLGTSSPFFSVNK | 2916 | Q6V1P9 | |
| ASSSSLEKSYELPDG | 931 | Q6S8J3 | |
| LYDALFSSQSPKDTS | 386 | A6NKT7 | |
| GLFTYSLSTKRSSPD | 126 | Q9UM11 | |
| RSSALASKATGYPLA | 721 | P31327 | |
| TVASFYTTKLLDSPG | 2291 | Q3L8U1 | |
| FYTAPKSDTSISDFL | 451 | Q4AC94 | |
| SKDLFVPTSSSLYGC | 66 | Q6ZS62 | |
| TLSGDSPLSKYRALF | 116 | A2CJ06 | |
| SDASPSGSPVLASYK | 176 | Q53HC0 | |
| FGAKSLTYPGDTTSA | 406 | Q4ZHG4 | |
| KSAFSPLQTTSASYG | 406 | Q5VZB9 | |
| GEYTSFLAPISSSKL | 466 | O14744 | |
| FFKTLLSSSPEYGAE | 166 | Q9P203 | |
| LSYALTSPDASYLGS | 286 | Q9UPI3 | |
| TSLSPTSKLGYSYSR | 756 | Q8NDI1 | |
| FSASLPALGFSTYSV | 566 | O00754 | |
| PGKDTFYSLGSSLDI | 101 | O00187 | |
| SQYSFAGSSIDLPLL | 86 | Q9Y2T3 | |
| YAASSLQSGVPSKFS | 71 | P04430 | |
| KYGLLSNEPSSSSTS | 571 | Q8IWT3 | |
| LFKSSRYDPSISFSG | 986 | Q9Y4K1 | |
| GSALSPITDFKLYAS | 736 | P42658 | |
| KLYESELTLFSSPFS | 841 | Q86UP8 | |
| KLYESELTLFSSPFS | 841 | Q6EKJ0 | |
| SSTASRLGSILSPYF | 466 | O76082 | |
| LSSSPEAKYDAFLVT | 686 | Q13822 | |
| GLSLYFPSKITASAV | 311 | Q6VVB1 | |
| ESLAKPSSFLYVSGA | 1361 | Q6ZRI0 | |
| DRSLYLSPKSSSASS | 76 | A7E2F4 | |
| LYDALFSSQSPKDTS | 386 | Q7Z3J3 | |
| LSTAFATASKPYLQL | 106 | Q3MII6 | |
| LSYSDGTTAPLSLYS | 731 | Q6IEE7 | |
| ALSYAISSPLFGLLS | 281 | Q6NT16 | |
| ALYSDPKSLETSAFV | 401 | Q9HB40 | |
| GSISYLPSFFTKLEN | 2186 | O75376 | |
| PASAVSGLYFSNLKS | 1211 | Q99707 | |
| SSGSSSPLYSKNVDL | 1371 | Q8IVL1 | |
| SLSSYTPDVAFGSKD | 271 | Q9P0U3 | |
| LFKGPITSYSKDASS | 581 | Q5T5P2 | |
| LSSALSKGATVYSPS | 1221 | Q9C0A6 | |
| YTLALPSDSGALSAL | 236 | Q9Y2G9 | |
| ASSSSLEKSYELPDG | 931 | P0CG38 | |
| SLSSGALPYKTSASE | 306 | Q86SQ0 | |
| YATPSADFLLKSSFS | 466 | A6NFN9 | |
| STLGSYSLPGTLAKS | 86 | P13682 | |
| EFYKTPSLSSSGSSD | 926 | Q13107 | |
| SGSSSSTKYDPDILK | 151 | Q6AWC2 | |
| GSLASNPYSGDLTKF | 851 | Q14157 | |
| CPSGSSLTYSALDVK | 166 | Q68D42 | |
| KYALLPSSSSSSEND | 246 | Q6ZNA4 | |
| SESSFEYGPLLKSSE | 146 | Q9HAI6 | |
| LYFLSSPLKPLSSSG | 2876 | Q15413 | |
| FSAILKSLQSYFSPT | 1556 | Q9Y5Y9 | |
| VTYLTFSALSSKPAE | 271 | Q86VE9 | |
| PKFSISATYDLGATL | 306 | P05543 | |
| VSSFAASLFLGSYSP | 196 | O75191 | |
| KSFDYGSLSLTGPSA | 1011 | Q5T1R4 | |
| YSFSLTTFSPSGKLV | 6 | P25787 | |
| SPLFGYELSSGTKET | 106 | Q9UBV4 | |
| SSILKTSQLGDSPFY | 246 | P49790 | |
| KAPLSKSALPYSSFS | 701 | P49750 | |
| KSALPYSSFSSDQGL | 706 | P49750 | |
| ELFSSSSPSKIYGRA | 131 | Q9BVV7 | |
| LLSGYPSSSSLASAA | 551 | Q96F45 | |
| AYKGLASPAYLSLSS | 276 | Q9Y210 | |
| VYPDSFSGVSLFSLS | 611 | O60602 | |
| SGLKVSEYSLPSDAT | 636 | A4D1P6 | |
| YFATKSSPTGVILDL | 881 | O95185 | |
| YKGLASPAYLSLSSE | 206 | Q13507 | |
| LAGFTYRPLATSTKD | 246 | Q8TF71 | |
| SLTSPLLFTASGYLS | 266 | Q15049 | |
| STTKPGLSEKSTTFY | 626 | Q9UKN1 | |
| GLSEKSTTFYSSPRS | 631 | Q9UKN1 | |
| GLSEKSTTFYSSPRS | 1686 | Q9UKN1 | |
| TAGLSEKSTTFYSSP | 3241 | Q9UKN1 | |
| GLSEKSTTFYSSPRS | 4326 | Q9UKN1 | |
| ASSKGTLTYLADSPS | 781 | E9PAV3 |